Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech North Carolina.
Press releases published on November 25, 2025
November 25, 2025
RedCloud’s CEO Floyd To Join NVIDIA, Google, Amazon, At Exclusive AI Summits in Tokyo and Doha
Indeterminate
GlobeNewswire
November 25, 2025
Synaptics to Participate at Upcoming Investor Conferences on Tuesday, December 2, 2025 and Wednesday, December 10, 2025
Indeterminate
GlobeNewswire
November 25, 2025
Telnyx and Yeastar partner to empower businesses with complete control over their Unified Communications
Indeterminate
GlobeNewswire
November 25, 2025
Compliant Launches Agentic AI Suite for Programmatic Media
Indeterminate
GlobeNewswire
November 25, 2025
Akari Therapeutics Announces Release of the Next CEO Corner Segment
Indeterminate
GlobeNewswire
November 25, 2025
INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025
Indeterminate
GlobeNewswire
November 25, 2025
Ragic Shortlisted in The 2025/26 Cloud Awards
Indeterminate
GlobeNewswire
November 25, 2025
Sagtec Delivers 226% Surge in Net Profit as Revenue Nearly Doubles in 2025 Interim Results
Indeterminate
GlobeNewswire
November 25, 2025
Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital
Indeterminate
GlobeNewswire
November 25, 2025
Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference
Indeterminate
GlobeNewswire
November 25, 2025
Helport AI and UMass Lowell Launch AI Entrepreneurship Competition
Indeterminate
GlobeNewswire
November 25, 2025
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Anticipates Major Fair-Value Uptick Following New Independent JV Valuation
Indeterminate
GlobeNewswire
November 25, 2025
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment
Indeterminate
GlobeNewswire
November 25, 2025
BlackLine Issues Statement Regarding Shareholder Engagement
Indeterminate
GlobeNewswire
November 25, 2025
Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program
Indeterminate
GlobeNewswire
November 25, 2025
Lexicon Pharmaceuticals to Participate in Two Upcoming December Investor Conferences
Indeterminate
GlobeNewswire